Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts

An In Vivo Mouse Model for Human Prostate Cancer Metastasis

(2015) Aaron M. Havens et al.   NEOPLASIA

Introduction

(2010) John Fitzpatrick   BJU INTERNATIONAL

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

(2009) Cigdem Erten et al.   BJU INTERNATIONAL

Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer

(2009) Ralph Graeser et al.   PANCREAS

The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data

(2008) Cristiana Lo Nigro et al.   BJU INTERNATIONAL

Chemotherapy in hormone-refractory prostate cancer

(2008) Ronald de Wit   BJU INTERNATIONAL

Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy

(2008) S. A. Veltkamp et al.   ONCOLOGIST